Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q9NZT2: Variant p.Ser577Thr

Opioid growth factor receptor
Gene: OGFR
Feedback?
Variant information Variant position: help 577 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LB/B The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Serine (S) to Threonine (T) at position 577 (S577T, p.Ser577Thr). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from small size and polar (S) to medium size and polar (T) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 577 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 677 The length of the canonical sequence.
Location on the sequence: help SPSETPGPRPAGPAGDEPAE S PSETPGPSPAGPTRDEPAES The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         SPSETPGPRPAGPAGDEPAESPSETPGP-SPAGPTRDEPAES

Mouse                         DPKGQVGPED--PKGQVGPEDPKSQVGPEDPKSQVEPEDPK

Rat                           DPNSQVGPED--PNSQVGPEDPNSQVGPEDPNSQV------

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 677 Opioid growth factor receptor
Repeat 577 – 596 4
Region 421 – 677 Disordered
Region 517 – 656 7 X 20 AA approximate tandem repeats of [ST]-P-S-E-T-P-G-P-[SR]-P-A-G-P-[AT]-[GR]-D-E-P-A-[EK]
Modified residue 557 – 557 Phosphoserine
Alternative sequence 558 – 577 Missing. In isoform 2.



Literature citations
Cloning, sequencing, chromosomal location, and function of cDNAs encoding an opioid growth factor receptor (OGFr) in humans.
Zagon I.S.; Verderame M.F.; Allen S.S.; McLaughlin P.J.;
Brain Res. 856:75-83(2000)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2); VARIANT THR-577; Genomic structure of human gene 7-60.
Takanosu M.; Liu J.; Mayne R.; Wood B.M.; Brewton R.G.;
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1); VARIANT THR-577; Characterization of long cDNA clones from human adult spleen.
Hattori A.; Okumura K.; Nagase T.; Kikuno R.; Hirosawa M.; Ohara O.;
DNA Res. 7:357-366(2000)
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 37-677 (ISOFORM 1); VARIANT THR-577;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.